Francesca Callegari

Long-term Safety of Rivastigmine in Parkinson Disease Dementia

Murat Emre, Werner Poewe, Peter Paul De Deyn et al. · Clinical Neuropharmacology · 2014 · 74 citations

Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy

Andrew S.C. Rice, Robert H. Dworkin, Nanna Brix Finnerup et al. · Pain · 2021 · 47 citations

Pain Therapy, Pain Medicine, Receptor Antagonist +19

Asymptotic inference in time series regressions with a unit root and infinite variance errors

Francesca Callegari, Nunzio Cappuccio, Diego Lubian · Journal of Statistical Planning and Inference · 2003 · 18 citations

Parameter Estimation, Engineering, Asymptotic Inference +8

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

Zhenxin Zhang, Zhen Hong, Yanping Wang et al. · CNS Neuroscience & Therapeutics · 2016 · 18 citations · Full text

Stimulus-Evoked Activity Modulation of In Vitro Engineered Cortical and Hippocampal Networks

Francesca Callegari, Martina Brofiga, Fabio Poggio et al. · Micromachines · 2022 · 18 citations · Full text

Neural Recoding, Electrical Stimulation Protocol, Neurotransmission +20